Prostate Cancer Coverage from Every Angle

Ryan Phillips, MD, PhD, on Observation or Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer?

Posted: Monday, September 30, 2019

Ryan Phillips, MD, PhD, of Johns Hopkins Medical Institutions, discusses which patients with oligometastatic prostate cancer might benefit from stereotactic ablative radiation therapy, given the results of the ORIOLE trial.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.